Deargen (디어젠)
Deargen (디어젠)
Claim
DearGen is focused drug design and development using artificial intelligence. DearGen develops Dr. UG, an AI platform for target discovery based on deep learning technology. The company specializes in genome data analysis, biomarker prediction, molecule selection and optimization.DearGen is focused drug design and development using artificial intelligence. DearGen develops Dr. U Show More
Alpha Score
$ 20.67 M
Alpha Score
65.0
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0